MetaCap

Rani Therapeutics Statistics

NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5111-0.0695 (-11.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rani Therapeutics by the numbers

Rani Therapeutics has a market capitalization of $59.0 million based on 115.49M shares outstanding. With trailing EPS of $-0.06, Rani Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% below its 50-day average and 41.7% below its 200-day average.

Average daily trading volume is 545.67K shares, or about $278,892 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RANI valuation vs. peer median

RANI compared with the median of 8 peer companies
MetricRANIPeer medianDifference
Market cap$59.03M$56.30M+5%
Avg. volume545.67K206.41K+164%

Peer median across 8 companies: TENX, IBIO, KZIA, VTVT, AZR, BOLD, FBIO, XLO.

Valuation

Market cap
$59.03M
Price / sales (latest FY)
36.15
EPS (TTM)
$-0.06

Price and trading

Previous close
0.5806
Open
0.58
Day range
0.5101 – 0.5819
52-week range
0.502 – 1.69
52-week change
-68.64%
Beta
—
Volume
457.42K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
59.03M
Forward Pe
-2.69
Eps
-0.06
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.69
Week52 Low
0.50
Avg Volume
545.67K
Shares Outstanding
115.49M
Ma50
0.68
Ma200
0.88
Earnings Date
Nov 10, 2026
Pct From52w High
-69.76%
Pct From52w Low
1.81%

Related